A Prospective Study of Apatinib in Patients with Extensive‐Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy

BACKGROUND: Because of rapid disease progression and lack of optimal treatment strategies beyond the second‐line, the prognosis of patients with extensive‐stage (ES) small cell lung cancer (SCLC) still remains depressing. Alternative treatment strategies are required to improve their prognosis. In t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Liu, Yutao, Hu, Xingsheng, Jiang, Jun, Yang, Lin, Zhou, Shengyu, Liu, Peng, Li, Junling, Wang, Yan, Hao, Xuezhi, Shi, Yuankai
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2020
Soggetti:
Lung Cancer
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216448/
https://ncbi.nlm.nih.gov/pubmed/32250517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0391
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi